Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Debt (2017 - 2018)

Autolus Therapeutics' Total Debt history spans 2 years, with the latest figure at $285000.0 for Q4 2018.

  • For Q4 2018, Total Debt changed N/A year-over-year to $285000.0; the TTM value through Dec 2018 reached $285000.0, changed N/A, while the annual FY2018 figure was $380000.0, 50.2% down from the prior year.
  • Total Debt reached $285000.0 in Q4 2018 per AUTL's latest filing, down from $380000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $763000.0 in Q3 2017 to a low of $285000.0 in Q4 2018.